Roche Holding AG (XSWX:RO) Cash Flow from Operations: CHF18,852 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:RO Roche Holding AG XSWX:RO
76 GF Score
Price CHF336.20
GF Value CHF268.98
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Cash Flow from Operations?

Roche Holding AG XSWX:RO -1.41% 76 Cash Flow from Operations is CHF18,852 Mil as of Dec. 2025. GuruFocus rates XSWX:RO with a GF Score™ of 76/100 and a GF Value™ of CHF268.98 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Dec. 2025, Roche Holding AG's Net Income From Continuing Operations was CHF5,967 Mil. Its Depreciation, Depletion and Amortization was CHF1,688 Mil. Its Change In Working Capital was CHF1,813 Mil. Its cash flow from deferred tax was CHF1,418 Mil. Its Cash from Discontinued Operating Activities was CHF0 Mil. Its Asset Impairment Charge was CHF0 Mil. Its Stock Based Compensation was CHF465 Mil. And its Cash Flow from Others was CHF401 Mil. In all, Roche Holding AG's Cash Flow from Operations for the six months ended in Dec. 2025 was CHF11,752 Mil.


Roche Holding AG  (XSWX:RO) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Roche Holding AG's net income from continuing operations for the six months ended in Dec. 2025 was CHF5,967 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Roche Holding AG's depreciation, depletion and amortization for the six months ended in Dec. 2025 was CHF1,688 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Roche Holding AG's change in working capital for the six months ended in Dec. 2025 was CHF1,813 Mil. It means Roche Holding AG's working capital increased by CHF1,813 Mil from Jun. 2025 to Dec. 2025 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Roche Holding AG's cash flow from deferred tax for the six months ended in Dec. 2025 was CHF1,418 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Roche Holding AG's cash from discontinued operating Activities for the six months ended in Dec. 2025 was CHF0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Roche Holding AG's asset impairment charge for the six months ended in Dec. 2025 was CHF0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Roche Holding AG's stock based compensation for the six months ended in Dec. 2025 was CHF465 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Roche Holding AG's cash flow from others for the six months ended in Dec. 2025 was CHF401 Mil.


Roche Holding AG Cash Flow from Operations Related Terms


Roche Holding AG Cash Flow from Operations Historical Data

* Premium members only.

The historical data trend for Roche Holding AG's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Cash Flow from Operations Chart

Roche Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20,976.00 17,803.00 16,095.00 20,094.00 18,852.00

Roche Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,197.00 7,914.00 12,180.00 7,100.00 11,752.00
XSWX:RO
76GF Score
Roche Holding AG XSWX:RO
Cash Flow from Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roche Holding AG Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Roche Holding AG's Cash Flow from Operations for the fiscal year that ended in Dec. 2025 is calculated as:

Roche Holding AG's Cash Flow from Operations for the quarter that ended in Dec. 2025 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF18,852 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Operations of CHF18,852 Mil mean?
Roche Holding AG (XSWX:RO) has a Cash Flow from Operations of CHF18,852 Mil as of Dec. 2025. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Roche Holding AG and its competitors.
Is Roche Holding AG's Cash Flow from Operations too high?
Roche Holding AG's current Cash Flow from Operations is CHF18,852 Mil. Overall, Roche Holding AG has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's Cash Flow from Operations compare to LLY and JNJ?
Roche Holding AG's Cash Flow from Operations of CHF18,852 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Operations for a Drug Manufacturers company?
A good Cash Flow from Operations depends on the Drug Manufacturers industry context. However, Cash Flow from Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Operations mean?
A high Cash Flow from Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Roche Holding AG and its competitors. Roche Holding AG's current Cash Flow from Operations is CHF18,852 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (XSWX:RO) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF268.98, compared to a current price of CHF336.20 — trading 25% above its estimated fair value. The current Cash Flow from Operations is CHF18,852 Mil. Roche Holding AG's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Operations calculated?
Cash Flow from Operations is calculated from a company's financial statements. For Roche Holding AG (XSWX:RO), the current Cash Flow from Operations is CHF18,852 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Roche Holding AG (XSWX:RO) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF336.20 is trading 25% above its estimated GF Value™ of CHF268.98. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for XSWX:RO:

  • Cash Flow from Operations: CHF18,852 Mil
  • GF Value™: CHF268.98 vs. price of CHF336.20 (25% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the XSWX:RO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
76GF Score

Get the complete analysis for XSWX:RO

Cash Flow from Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF336.20
Price
CHF268.98
GF Value